More Americans diagnosed with cancer are now surviving the disease - marking a positive trend that experts say reflects the ...

A multitargeted T-cell therapy produced encouraging activity in a preliminary study of patients with pancreatic cancer, ...

Cancer diagnoses are both more common and more survivable than ever. The question is whether you can afford life-saving ...

Gastroenterology specialists Dr Andy Li and Dr Jessica Gurung outline a rational approach to investigating recurrent ...

Bicara Therapeutics (NASDAQ:BCAX) used its presentation at the 44th Annual J.P. Morgan Healthcare Conference to outline its ...

Investigators designed and externally validated a prostate cancer death prediction model for risk stratification of men at the point of PSA screening.

Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 months Notable responses were ...

Despite the promising cancer news, medical progress faces hurdles as Medicare telehealth coverage ends and ACA enrollment ...

The Cancer Biomarkers Market is poised for robust expansion driven by escalating industry demand, accelerated technological innovation, and expanding clinical adoption. Rising global cancer ...

More Americans are surviving cancer, with overall five-year survival reaching 70 percent for the first time. Gains are driven ...

Oncolytics also recently expanded its Scientific Advisory Board with globally recognized experts from Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center, positioning the company for ...

The presence of circulating tumor DNA (ctDNA) in patients with human epidermal growth factor receptor 2 (HER2)-positive ...